Prognosis assessment of CD44+/CD24− in breast cancer patients: a systematic review and meta-analysis

被引：0
|
作者：
Jingjing Gu
Dandan Chen
Zhiqiang Li
Yongliang Yang
Zhaoming Ma
Guanhong Huang
机构：
[1] Lianyungang Second People’s Hospital Affiliated to Bengbu Medical College,
来源：
Archives of Gynecology and Obstetrics | 2022年 / 306卷
关键词：
CD44; /CD24; Breast cancer; Meta-analysis; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1147 / 1160
页数：13
相关论文
共 50 条
  • [21] CD24 polymorphisms in breast cancer: impact on prognosis and risk
    Buck, Katharina
    Hug, Sarah
    Seibold, Petra
    Ferschke, Irmgard
    Altevogt, Peter
    Sohn, Christof
    Schneeweiss, Andreas
    Burwinkel, Barbara
    Jaeger, Dirk
    Flesch-Janys, Dieter
    Chang-Claude, Jenny
    Marme, Frederik
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (03) : 927 - 937
  • [22] CD44+/CD24− cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast
    Daniel Guimarães Tiezzi
    Fernando Antonio Mourão Valejo
    Heitor Ricardo Cosinski Marana
    Hélio Humberto Angotti Carrara
    Luciana Benevides
    Heriton Marcelo Ribeiro Antonio
    Renata Danielle Sicchieri
    Cristiane Maria Milanezi
    João Santana da Silva
    Jurandyr Moreira de Andrade
    Medical Oncology, 2012, 29 : 1479 - 1485
  • [23] Sox9 upregulation in breast cancer is correlated with poor prognosis and the CD44+/CD24-/low phenotype
    Lei, Bo
    Zhang, Youxue
    Liu, Tong
    Li, Yiwen
    Pang, Da
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7345 - 7351
  • [24] Clinical Implications of CD44+/CD24-Tumor Cell Ratio in Breast Cancer
    Liu, Caigang
    Luo, Yang
    Liu, Xing
    Lu, Ping
    Zhao, Zuowei
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (05) : 324 - 328
  • [25] Reduction of CD44+/CD24- breast cancer cells by conventional cytotoxic chemotherapy
    Aulmann, Sebastian
    Waldburger, Nina
    Penzel, Roland
    Andrulis, Mindaugas
    Schirmacher, Peter
    Sinn, Hans Peter
    HUMAN PATHOLOGY, 2010, 41 (04) : 574 - 581
  • [26] Clinicopathological and Prognostic Significance of CD24 Overexpression in Patients with Gastric Cancer: A Meta-Analysis
    Wu, Jing-Xun
    Zhao, Yuan-Yuan
    Wu, Xuan
    An, Han-Xiang
    PLOS ONE, 2014, 9 (12):
  • [27] CD44+/CD24- cancer stem cell in breast tissue distribution and prevalence
    Swiatek, J.
    Kaerner, A.
    Heil, J.
    Aulmann, S.
    Sinn, H.
    Sohn, C.
    Gebauer, G.
    ONKOLOGIE, 2008, 31 : 51 - 52
  • [28] CD44+ enriches for cancer initiating cells while CD44+CD24+ and CD44+CD24- cells are equally tumorigenic in basal-like breast cancer
    Vonderhaar, B.
    Meyer, M.
    Fleming, J.
    Ginsburg, E.
    Bush, A.
    Ali, M.
    Lieber, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 19 - 19
  • [29] The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast CD44/CD24 expression in breast cancer
    Kapucuoglu, Nilgun
    Bozkurt, Kemal Kursat
    Baspinar, Sirin
    Kocer, Murat
    Eroglu, Hasan Erol
    Akdeniz, Rasit
    Akcil, Mehtap
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (10) : 740 - 747
  • [30] Grp78 as a therapeutic target for refractory head–neck cancer with CD24−CD44+ stemness phenotype
    C-C Chiu
    L-Y Lee
    Y-C Li
    Y-J Chen
    Y-C Lu
    Y-L Li
    H-M Wang
    J T Chang
    A-J Cheng
    Cancer Gene Therapy, 2013, 20 : 606 - 615
12345